Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of stable α crystal form perindopril tert-butylamine tablet and its preparation method

A technology of tert-butylamine tablets and perindopril, which is applied in the field of medicine, can solve the problems of impurity degradation rate and difficult crystal form transformation, and achieve the effect of reducing water control and disintegration risks, using fewer types of excipients, and facilitating stability

Active Publication Date: 2019-06-18
NINGBO MENOVO TIANKANG PHARMA CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In summary, the degradation rate and crystal transformation of impurities in the stability of perindopril are the difficulties in product development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of stable α crystal form perindopril tert-butylamine tablet and its preparation method
  • A kind of stable α crystal form perindopril tert-butylamine tablet and its preparation method
  • A kind of stable α crystal form perindopril tert-butylamine tablet and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A kind of perindopril tablet, described perindopril tablet is made up of following components according to parts by weight:

[0039] Alpha crystal form perindopril tert-butylamine: 4 parts;

[0040] Lactose: 65 parts;

[0041] Microcrystalline cellulose: 20 parts;

[0042] Magnesium stearate: 1 part.

[0043] The tablet weighing about 90mg of last system, its preparation process comprises the following steps:

[0044] (1) Take lactose and microcrystalline cellulose and pass through a 50-mesh sieve respectively, mix, dry until the moisture is lower than 4.5%, divide into 3 parts, and control the humidity in the process to be lower than 40% RH.

[0045] (2) Take one portion and mix it with perindopril tert-butylamine passing through a 80-mesh sieve, and pass through a 60-mesh sieve to mix;

[0046] (3) Continue to add a part of the mixed auxiliary materials in (1) and mix;

[0047] (4) Mix (3) with the remaining auxiliary materials in (1) for 20 minutes;

[0048] (5) ...

Embodiment 2

[0054] Embodiment 2: a kind of perindopril tablet, described perindopril tablet is made up of following components according to parts by weight:

[0055] Alpha crystal form perindopril tert-butylamine: 4 parts;

[0056] Lactose: 60 parts;

[0057] Microcrystalline cellulose: 25 parts;

[0058] Magnesium stearate: 1 part.

[0059] The tablet weighing about 90mg of last system, its preparation process comprises the following steps:

[0060] (1) Take lactose and microcrystalline cellulose and pass through a 50-mesh sieve respectively, mix, dry until the moisture is lower than 4.5%, divide into 3 parts, and control the humidity in the process to be lower than 40% RH;

[0061] (2) Take one portion and mix it with perindopril tert-butylamine through a 60-mesh sieve, and mix evenly through a 60-mesh sieve;

[0062] (3) Continue to add a part of the mixed auxiliary materials in (1) and mix;

[0063] (4) Mix (3) with the remaining auxiliary materials in (1) for 20 minutes;

[006...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
hardnessaaaaaaaaaa
Login to View More

Abstract

The invention provides a stable alpha-crystalline form perindopril tert-butylamine tablet, which consists of perindopril tert-butylamine, lactose, microcrystalline cellulose and magnesium stearate. A preparation method, by virtue of a powder direct compression process, comprises the following steps: firstly, sieving and mixing the lactose and the microcrystalline cellulose, and drying the lactose and the microcrystalline cellulose; respectively sieving and mixing some lactose and microcrystalline cellulose with perindopril tert-butylamine; finally, adding the magnesium stearate and mixing; sampling and detecting, tabletting and packaging an obtained tablet with an aluminum-plastic foamed mask, wherein the interior of the aluminum-plastic foamed mask contains a drying agent and the exterior of the aluminum-plastic foamed mask is covered by a composite film bag. The perindopril tert-butylamine tablet prepared by the method disclosed by the invention has no significant change with published products in character, dissolution rate, moisture, content, crystalline form as well as dissolution behaviors in mediums at different pH values, and the perindopril tert-butylamine tablet is more stable than the published products in production and storage stability, so that the clinical effectiveness and safety of the medicine during taking are guaranteed. The perindopril tert-butylamine tablet preparation method provided by the invention is simple, and the production cost of the medicine is reduced.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a stable α-crystal form perindopril tert-butylamine tablet and a preparation method thereof. Background technique [0002] Perindopril and its salts belong to angiotensin and are widely used in the treatment of cardiovascular diseases, especially in the fields of hypertension and heart failure. Although perindopril was initially synthesized in the form of sodium salt, its stability was not good, so more stable perindopril tert-butylamine and arginine salts were successively synthesized, which also reduced the safety risk. Perindopril arginine salt and perindopril tert-butylamine have been developed into various forms of single or compound preparations. Traditional perindopril tert-butylamine tablet formulations often use fillers (such as lactose, microcrystalline cellulose) , binders (such as hydroxypropyl cellulose, povidone, hydroxypropyl methyl cellulose), disint...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K38/05A61K47/38A61K47/26A61P9/12A61P9/04A61P9/00
CPCA61K9/2018A61K9/2054A61K38/05
Inventor 姚成志余永华石晓宝
Owner NINGBO MENOVO TIANKANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com